QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable
Generate Biomedicines says AI could make biology programmable by generating and testing drug hypotheses at machine scale.
A biotech company thinks AI might help scientists design new medicines much faster by testing thousands of ideas automatically. When a company backed by smart investors talks about big breakthroughs like this, it's worth watching whether their ideas actually work in real life.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.